2018
Gurugram (India)
Series E
Pristyn Care is a leading health-tech company specializing in minimally invasive surgical and medical interventions, it operates through a robust network of over 800 partner hospitals, 150+ clinics, and a panel of 400+ super-specialist surgeons, providing advanced surgical solutions in specialties such as proctology, urology, gynecology, ENT, vascular, laparoscopy, and ophthalmology.
Pristyn Care operates on a hybrid healthcare delivery model, integrating digital technology with a network of partner hospitals and clinics.Its primary revenue streams are:
Surgical and Healthcare Service Fees: The largest revenue source comes from fees charged to patients for surgeries and associated healthcare services, including diagnostics, pre-operative, and post-operative care.
Insurance Partnerships: Pristyn Care has tie-ups with insurance providers to offer cashless treatments. The company receives reimbursements or commissions for facilitating insurance claims and processing, which adds a significant revenue stream.
Direct Patient Payments: Patients without insurance coverage pay out-of-pocket for procedures, consultations, and bundled care packages, providing a steady cash flow.
Subscription Plans: The company offers premium health management plans on a subscription basis, giving patients access to personalized and priority healthcare services for a monthly or annual fee.
Value-Added Services: Additional revenue is generated from services such as telemedicine consultations, remote monitoring, physiotherapy, and medical supplies, often bundled as post-surgery care packages.
Partnership and Referral Fees: Pristyn Care earns referral fees and commissions through collaborations with hospitals, clinics, and diagnostic centers, expanding its reach and service portfolio.
B2C : Individual patients seeking elective or minimally invasive surgeries.
B2B: Partnerships with hospitals, clinics, diagnostic centers, and insurance companies.
Pristyn Care’s growth strategy is multi-pronged:
Geographic Expansion: Aggressively expanding to new cities and semi-urban/rural areas to tap into underserved markets, supported by digital platforms and telemedicine.
Service Diversification: Broadening its portfolio to include new surgical specialties (e.g., orthopedics, cosmetic surgery) and entering primary healthcare through acquisitions.
Technology Integration: Investing in AI, data analytics, and advanced surgical technologies to enhance patient outcomes and operational efficiency.
Strategic Partnerships: Collaborating with leading hospitals, insurance providers, and technology companies to scale operations and improve service quality.
Continuous Innovation: Focus on R&D for new surgical techniques and patient engagement initiatives.
Unlike traditional hospital chains, Pristyn Care’s asset-light and technology-driven model allows for rapid scalability and lower overheads. Its focus on minimally invasive, elective surgeries-combined with digital patient journeys and comprehensive aftercare-sets it apart from both legacy hospitals and pure-play telemedicine startups. The company’s ability to offer bundled services, cashless insurance options, and personalized care at scale is a key differentiator in the competitive Indian healthcare landscape.
Pristyn Care’s unique blend of technology, strategic partnerships, and patient-centric services has enabled it to disrupt the elective surgery segment in India, making it a compelling case study for investors and industry observers .
$181 Million
5
$100 Million, Series E
as of December 7, 2021
$1.4 Billion
as of December 7, 2021
7.73
as of December 7, 2021
Sequoia Capital
and 3 more1497
Proactive For Her
N/A
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
December 7, 2021 | Series E | $100 Million | $1.4 Billion | $37.5 Million | - | Tiger Global Management, Hummingbird Ventures, Epiq Capital Advisors, Trifecta Capital, Rockstone Ventures, Sequoia Capital, QED Innovation Labs, Amber Winter, Peak XV Partners |
April 16, 2021 | Series D | $53 Million | $551 Million | $16.2 Million | - | Tiger Global Management, Hummingbird Ventures, Epiq Capital Advisors, Peak XV Partners, Sequoia Capital |
September 24, 2020 | Series C | $11.7 Million | $250 Million | $8.8 Million | - | Epiq Capital Advisors, Hummingbird Ventures, Greenoaks, Peak XV Partners, Sequoia Capital |
November 14, 2019 | Series B | $12 Million | $103 Million | $2.9 Million | - | Hummingbird Ventures, Greenoaks, Peak XV Partners, Sequoia Capital |
January 29, 2019 | Series A | $4 Million | $146 Million | - | - | Sequoia Capital, Peak XV Partners |